3D organoids are becoming popular in drug discovery and disease modeling as they better represent biologically relevant microenvironments. However, the protocols for organoid assays are complex and often require labor-intensive monitoring by highly trained specialists. In addition, there is a lack of clarity about automation’s contribution to increasing assay throughput, scalability, and workflow reliability, while still reducing overall cost.
In this webinar, experts share strategies to deliver relevant complex biological models at scale and clarify the role automation plays in the future of drug discovery. In addition, they examine how to address the complexities that come with translating bench protocols to automated methods and discuss best practices for automating cell and organoid workflows. Key takeaways include: